If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Kisunla ™ (donanemab-azbt) injection, for intravenous infusion
350 mg/20 mL (17.5 mg/mL)
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Are samples available for Kisunla™ (donanemab-azbt)?
Samples are not available for Kisunla.
Detailed Information
Samples are not available for Kisunla (donanemab).
Date of Last Review: February 23, 2024